225 filings
Page 3 of 12
424B5
sk8wp vx0w3x4r6jf4
31 May 22
Prospectus supplement for primary offering
5:15pm
8-K
mu1uqyqpj4 ks7tkpdj
23 May 22
Regulation FD Disclosure
7:18am
8-K
yi5bmwucxi 4ir
12 May 22
Other Events
8:44am
8-K
autuh8tizkg0
5 May 22
Concert Pharmaceuticals Reports First Quarter 2022 Financial Results
7:02am
EFFECT
ow2e265o4h852 fxp
29 Apr 22
Notice of effectiveness
12:15am
DEFA14A
0e1cwu
26 Apr 22
Additional proxy soliciting materials
7:06am
CORRESP
q2ru cwuwbc8nl
26 Apr 22
Correspondence with SEC
12:00am
UPLOAD
h1rgjun htdomhcl9
8 Mar 22
Letter from SEC
12:00am
S-8
j8pq1 aiig
3 Mar 22
Registration of securities for employees
6:08am
8-K
itzd0rkam li3g
3 Mar 22
Concert Pharmaceuticals Reports 2021 Financial Results and Provides Company Update
6:03am
8-K
du4emg p64mzr
3 Feb 22
Departure of Directors or Certain Officers
4:06pm
8-K
d7getr9lr l53rh03wy3
9 Nov 21
Concert Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company Update
7:04am
8-K
85u7oswf
8 Nov 21
Concert Pharmaceuticals Announces $65 Million Financing
9:15am
424B5
jku em7o4fc6hv3
5 Nov 21
Prospectus supplement for primary offering
1:07pm